Jericho Assisted Living
Thursday, April 6, 2017
ENDO: Liraglutide May Prevent Lipolysis, Ketogenesis in T1D (CME/CE)
(MedPage Today) -- Favorable results from placebo-controlled trial
via
ENDO: Liraglutide May Prevent Lipolysis, Ketogenesis in T1D (CME/CE)
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment